Causes of death among people living with HIV/AIDS in Brazil

Brazilian Journal of Infectious Diseases

Volumn 14, Issue 6, 2010, Pages 558-563

  Rezende, Erika Luiza Lage Fazito ^a   Vasconcelos, Ana Maria Nogales ^b   Pereira, Mauricio Gomes ^b  

^a MINISTÉRIO DA SAÚDE   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

AIDS; Causes of death; HIV

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; BEHAVIOR CHANGE; BRAZIL; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEATH CERTIFICATE; EDUCATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MORBIDITY; MORTALITY; QUALITY OF LIFE; SCHOOL CHILD; TREND STUDY;

ADOLESCENT; ADULT; BRAZIL; CAUSE OF DEATH; CROSS-SECTIONAL STUDIES; DEATH CERTIFICATES; FEMALE; HIV INFECTIONS; HUMANS; INFORMATION SYSTEMS; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 79955967131     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1413-8670(10)70112-4     Document Type: Article

References (29)

1. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa Nacional de DST e Aids. Boletim Epidemiológico AIDS DST, ano V, no 1, 2008.. Access: 03/20/2009. http://www.aids.gov.br/data/documents/storedDocuments/.
2. Organização Mundial de Saúde. CID-10: Classificação Estatística Internacional de Doenças e Problemas Relacionados à Saúde - Décima revisão. 2008. Volume 1. Available at: http://www.datasus.gov.br/cid10/v2008/cid10.htm.
3. Pinheiro CE, Santo AH. Processamento de causas de morte em lote pelo sistema de seleção de causa básica. Rev. Saúde Pública 1998; 32(1):72-3. Available at: Accessed on 05/27/2009. http://www.scielosp.org/scielo.php.
4. Matida LH, Ramos Jr NA, Moncau JEC et al. AIDS by mother-to-child transmission: survival analysis of cases followed from 1983 to 2002 in different regions of Brazil. Cad Saúde Pública (FIOCRUZ) 2007; 23(S3):435-44. Accessed: 03/20/2009. http://www.scielo.br/pdf/csp/v23s3/11.pdf.
5. Matida LH, Ramos Jr AN, Marques HHS et al. Ampliação da sobrevivência de crianças com aids: uma resposta brasileira sustentável. In: Brasil, Ministério da Saúde, Secretaria de Vigilância em Saúde. Programa Nacional de DST e Aids. Boletim Epidemiológico AIDS DST, ano V, no 1, 2008. Accessed: 03/20/2009. http://www.aids.gov.br/data/documents/storedDocuments/.
6. Marins J.R., Jamal L.F., Chen S.Y., et al. Dramatic improvement in survival among adult Brazilian AIDS patients. Aids 2003, 17:1675-1682.
7. Guibu IA, Barros MBA, Cordeiro MRD et al. Estudo de Sobrevida de Pacientes de AIDS no Brasil, 1998 a 1999 - Fase I - Regiões Sul e Sudeste. In: Brasil, Ministério da Saúde, Secretaria de Vigilância em Saúde. Programa Nacional de DST e Aids. Boletim Epidemiológico AIDS DST, ano V, no 1, 2008. Access: 03/20/2009. http://www.aids.gov.br/data/documents/storedDocuments.
8. SPSS [computer program]. Version 13.0 for windows. Release 13.0 (1 Sep 2004). Copyright © SPSS Inc., 1989-2004. All rights reserved. Network license user: Ministério da Saúde.
9. Krentz H.B., Kliewer G., Gill M.J. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med. 2005, 6:99-106. [PMID: 15807715].
10. Lau B., Gange S.J., Moore R.D. Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 Cells/mm3. J Acquir Immune Defic Syndr 2007, 44:179-187.
11. Sackoff J.E., Hanna D.B., Pfeiffer M.R., Toryan L.V. Causes of Death among Persons with AIDS in the Era of Highly Active Antiretroviral Therapy 2006, 145. Ann Intern Med, New York City, 397-406.
12. Crum N.F., Riffenburgh R.H., Wegner S., et al. Comparisons of causes of death and mortality rates among HIV infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 2006, 41:194-200. [PMID: 16394852].
13. Pacheco A.G., Tuboi S.H., Faulhaber J.C., Harrison L.H., Schechter M. Increase in non-AIDS related conditions as causes of death among HIV-infected individuals in the HAART era in Brazil. PLoS ONE 2008, 3:e1531.
14. Jain M.K., Skiest D.J., Cloud J.W., et al. Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000. Clin Infect Dis 2003, 36(8):1030-1038.
15. Marti{dotless}nez E., Milinkovic A., Buira E., et al. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV Med 2007, 8(4):251-258.
16. Palella F.J., Baker R.K., Moorman A.C., et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006, 43:27-34. HIV Outpatient Study Investigators.
17. Yang C.H., Huang Y.F., Hsiao C.F., et al. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005. British HIV Association HIV Medicine 2008, 9:535-543.
18. Pacheco A.G., Tuboi S.H., May S.B., et al. Temporal Changes in Causes of Death Among HIV-Infected Patients in the HAART Era in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 2009, 51(5):624-630.
19. Lewden C., Thierry M., Rosenthal E., et al. Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The " Mortalite 2000 and 2005" Surveys (ANRS EN19 and Mortavic). JAIDS 2008, 48(5):590-598.
20. Justman J.E., Benning L., Danoff A., et al. Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women. J Acquir Immune Defic Syndr 2003, 32(3):298-302.
21. Dever L.L., Onwari P.A., Figueroa W.E., O'Donovan C.A., Eng R.H. Hyperglycemia associated with protease inhibitors in an urban HIV-infected minority based population. Ann Pharmacother 2000, 34:580-584.
22. Carr A., Samaras K., Thorisdottir A., et al. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and DM: a cohort study. Lancet 1999, 353:2093-2099.
23. Dube M.P., Edmondson-Melancon H., Qian D., et al. Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIV-infected patients. J Acquir Immune Defic Syndr 2001, 27(2):130-134.
24. Stein M.D., Hanna L., Natarajan R., et al. Alcohol use patterns predict high-risk HIV behaviors among active injection drug users. Journal of Substance Abuse Treatment 2000, 18(4):359-363.
25. Windle M. The trading of sex for money or drugs, sexually transmitted diseases (STDs), and HIV-related risk behaviors among multisubstance using alcoholic inpatients. Drug and Alcohol Dependence 1997, 49(1):33-38.
26. Avins A.L., Woods W.J., Lindan C.P., et al. HIV infection and risk behaviors among heterosexuals in alcohol treatment programs. JAMA 1994, 271(7):515-518.
27. Boscarino J.A., Avins A.L., Woods W.J., et al. Alcohol-related risk factors associated with HIV infection among patients entering alcoholism treatment: Implications for prevention. Journal of Studies on Alcohol 1995, 6(6):642-653.
28. Malow R.M., Dévieux J.G., Jennings T., Lucenko B.A., Kalichman S.C. Substance-abusing adolescents at varying levels of HIV risk: Psychosocial characteristics, drug use, and sexual behavior. J Subst Abuse 2001, 13:103-117.
29. Weber R., Sabin C.A., Friis-Møller N., et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006, 166(15):1632-1641.